A clinical evaluation of Pippalyadi nasal spray with special reference to Nasal blockage

A clinical evaluation of Pippalyadi nasal spray for its Nasanahapratishedha activity in Nasanaha with special reference to Nasal blockage

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/03/008177

Enrollment

Registered

2017-03-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Nasal blockage

Interventions

Intervention1: PIPPLYADI NASAL SPRAY: Pippalyadi nasal spray will be prepared by taking drug powder of PIPER LONGUM, PIPER NIGRUM, MORINGA OLEIFERA AND EMBELIA RIBS drug, add 8 times of water to all

Eligibility

Inclusion criteria

Inclusion criteria: Patient having pratishyÄ?ya with the symptom of NÄ?sÄ?nÄ?ha (nasal blockage) and without fever. Chronic simple rhinitis with the symptom of NÄ?sÄ?nÄ?ha (nasal blockage) less than 6 month. Hypertrophic rhinitis with the symptom of NÄ?sÄ?nÄ?ha (nasal blockage) less than 6 month. NÄ?shÄ?rsha (1st degree nasal polyp)

Exclusion criteria

Exclusion criteria: Congenital anomalies of nose rhinitis with fever Atrophic rhinitis Rhinophyma Rhinitis sicca 2nd and 3rd degree nasal polyp Deviated nasal septum require surgical correction Perforation of nasal septum Septal haematoma Septal abscess bronchial asathama Perennial rhinitis

Design outcomes

Primary

Measure	Time frame
Improvement in Nasal blocking 7-14 daysTimepoint: Improvement in Nasal blocking in 7-14 days	—

Secondary

Measure	Time frame
NOT APPLICABLETimepoint: NOT APPLICABLE	—

Countries

India

Contacts

Public ContactDr Krishna Makadia

Government Akhanandanand Ayurved college

drkrishna1111@gmail.com9427410171

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026